The Nasdaq Composite experienced a crash earlier this year due to President Trump’s tariff announcements, but it quickly entered a
Kura Oncology presents new data on the potential of darlifarnib in combination with other targeted therapies to address resistance pathways
Two stocks that could potentially double your money in just a few years are Opendoor Technologies (NASDAQ: OPEN) and Dutch
Nurix Therapeutics presented new clinical data on NX-1607, showing evidence of monotherapy anti-tumor activity and on-target immune activation. Expansion cohorts
Olema Pharmaceuticals announced promising results from a Phase 1b/2 study of palazestrant with ribociclib in ER+ HER2- advanced breast cancer.
Corbus Pharmaceuticals announced positive results from their Phase 1/2 clinical study of CRB-701, showing an objective response rate of 47.6%
Netflix, Inc. (NASDAQ: NFLX) is listed among the 14 Best Big Name Stocks to Invest in Right Now, with analysts
Shares of AXON (NASDAQ:AXON) rose 3.2% after TD Cowen reiterated a Buy rating and $925.00 price target, expecting strong quarterly
Shares of Churchill Downs (NASDAQ:CHDN) rose 3.7% after investment firm Stifel reiterated its Buy rating with a $133.00 price target
Option Care Health (OPCH) saw a 3.2% increase in its stock price after Morgan Stanley gave it an ‘Overweight’ rating
Genentech, a member of the Roche Group, reported positive results from the Phase III evERA Breast Cancer study. The combination
Roche announced positive results from the evERA Breast Cancer study, showing giredestrant plus everolimus reduced disease progression risk by 44%
Amgen and AstraZeneca’s TEZSPIRE approved by FDA for chronic rhinosinusitis with nasal polyps in adults and pediatric patients 12 years
STEP Energy Services Ltd. has agreed to go private through an all-cash transaction with ARC Energy Fund 8. ARC will
Westhaven Gold Corp. announces the departure of VP Corporate Development & Investor Relations Sean Thompson. Red Cloud Securities returned 250,000
Pentair plc (NYSE: PNR) is recognized among the 15 Dividend Stocks that Have Raised Payouts for 20+ Years. JPMorgan and
CG Oncology, Inc. (NASDAQ:CGON) is identified as one of the best healthcare stocks with high potential by Guggenheim analyst Brad
Apogee Therapeutics Inc. (NASDAQ:APGE) is highlighted as one of the best healthcare stocks with the highest upside potential. BTIG analyst
nCino, Inc. (NASDAQ:NCNO) is upgraded to Outperform by William Blair, who sees an attractive entry point after recent sell-off in
Citizens reaffirmed its Market Perform rating for Upstart Holdings, Inc. (NASDAQ:UPST), one of the 12 Best Fintech Stocks to Buy
Viking Therapeutics (VKTX) is rated as one of the best healthcare stocks with high upside potential, receiving Buy ratings from
Samsung Electronics Chairman Jay Y. Lee’s mother and sisters plan to sell $1.22 billion worth of shares to cover tax
rYojbaba Co., Ltd. announced strategic developments and global partnerships to expand legal consulting and osteopathic clinic services internationally. CEO Ryoji
StoneX Group Inc. has completed its acquisition of Intercam Advisors, Inc. and Intercam Securities, Inc., rebranding them as StoneX International
In a recent podcast, Motley Fool contributors Tyler Crowe, Matt Frankel, and Jon Quast discussed the return of a meme